US Stock MarketDetailed Quotes

XERS Xeris Pharmaceuticals

Watchlist
  • 2.380
  • -0.050-2.06%
Close Aug 2 16:00 ET
  • 2.380
  • 0.0000.00%
Post 20:02 ET
352.85MMarket Cap-5063P/E (TTM)

Xeris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xeris Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 8, 2024

Revenue(YoY)

45.81M

+20.53%
EPS(YoY)

-0.11

+23.80%
Analyst Rating

Strong Buy

Jul 31, 2024

Xeris Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 49.210M--
Aug 8, 20242024/Q2-- / 45.811M--
May 9, 20242024/Q140.638M / 41.815M--
Mar 6, 20242023/Q444.390M / 43.552M--
Nov 9, 20232023/Q348.320M / 41.084M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 49.210M--
Aug 8, 20242024/Q2-- / 45.811M--
May 9, 20242024/Q140.638M / 41.815M--
Mar 6, 20242023/Q444.390M / 43.552M--
Nov 9, 20232023/Q348.320M / 41.084M--

Unlock Free Earnings Estimates

Xeris Pharmaceuticals Earnings Reports

  • Xeris Pharmaceuticals | 10-Q: Quarterly report

    May 9 16:27 ET

  • Xeris Pharmaceuticals | 10-K: Annual report

    Mar 6 16:15 ET

  • Xeris Pharmaceuticals: Q3 2023 Earnings Report

    Nov 9, 2023 16:10 ET

  • Xeris Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg